Celldex Therapeutics
CLDX
#4365
Rank
NZ$4.35 B
Marketcap
NZ$55.46
Share price
1.09%
Change (1 day)
82.89%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of December 2025 : NZ$3.97 Million

According to Celldex Therapeutics's latest financial reports the company's total debt is NZ$3.97 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-12-31NZ$4.03 M-40.34%
2024-12-31NZ$6.76 M68.2%
2023-12-31NZ$4.01 M-36.72%
2022-12-31NZ$6.35 M42.63%
2021-12-31NZ$4.45 M-7.69%
2020-12-31NZ$4.82 M-11.15%
2019-12-31NZ$5.43 M
2018-12-31N/A-100%
2017-12-31NZ$9.24 M
2015-12-31NZ$6.45 M95.13%
2014-12-31NZ$3.3 M
2013-12-31N/A-100%
2012-12-31NZ$13.78 M-28.97%
2011-12-31NZ$19.4 M38.38%
2010-12-31NZ$14.02 M-26.41%
2009-12-31NZ$19.05 M4972.41%
2008-12-31NZ$0.37 M-94.43%
2007-12-31NZ$6.74 M2.38%
2006-12-31NZ$6.59 M115.78%
2005-12-31NZ$3.05 M1068.46%
2004-12-31NZ$0.26 M
2000-12-31NZ$0.61 M-42.49%
1999-12-31NZ$1.07 M-64.52%
1998-12-31NZ$3.03 M10.11%
1997-12-31NZ$2.75 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
NZ$108.83 B 2,737,956.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$92.91 B 2,337,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$40.60 B 1,021,471.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ$0.19 B 4,758.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$77.88 M 1,859.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.12 B 28,286.13%๐Ÿ‡บ๐Ÿ‡ธ USA